The Board of Directors of CHEMCON Speciality Chemicals Limited, in their meeting held on May 21, 2026, approved the audited financial results for the quarter and financial year ended March 31, 2026. The company reported a revenue from operations of ₹75.42 Crores for the quarter ended March 31, 2026, compared to ₹57.33 Crores for the previous quarter (ended December 31, 2025) and ₹54.89 Crores for the corresponding quarter of the previous year (ended March 31, 2025). The Profit Before Tax (PBT) for the quarter ended March 31, 2026, was ₹31.96 Crores.

Note: Calculations are based on data from the audited financial results.

CHEMCON Speciality Chemicals Limited is a prominent Indian manufacturer specializing in pharmaceutical intermediates and oilfield chemicals. The company is recognized as a major producer of specialized chemicals such as Hexamethyldisilazane (HMDS) and Chloromethyl Isopropyl Carbonate (CMIC), which are essential in the pharmaceutical industry for generic drug production. In 2025, the company maintained its status as an ISO 9001:2015 and 14001:2015 certified entity, focusing on expanding its chemical manufacturing capabilities and strengthening its position in both domestic and international markets. The company’s growth strategy throughout 2025 remained centered on its role as an import substitution player in the chemical sector.